Sandip Kumar Baidya

Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches

Sandip Kumar Baidya, Suvankar Banerjee, Balaram Ghosh et al. · SAR and QSAR in environmental research · 2023 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Quantitative structural assessments of potential meprin β inhibitors by non-linear QSAR approaches and validation by binding mode of interaction analysis

Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh et al. · New Journal of Chemistry · 2023 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences

Nilanjan Adhikari, Suvankar Banerjee, Sandip Kumar Baidya et al. · Journal of Molecular Structure · 2021 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis, biological assessment, and in silico binding mode interaction analyses and DFT studies of biphenylsulfonamide-based potent MMP-2 inhibitors effective against chronic myeloid leukemia

Sandip Kumar Baidya, Tarun Patel, Ambati Himaja et al. · Journal of Molecular Structure · 2024 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis

Sandip Kumar Baidya, Suvankar Banerjee, Balaram Ghosh et al. · SAR and QSAR in environmental research · 2024 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15